← Evidence map

ReviewTherapeutics and clinical risk management2023

Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder.

Christina Shaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36647532